Litchev Boyan Vesselinov 4
4 · Indaptus Therapeutics, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Litchev Boyan Vesselinov
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-01+90,000→ 90,000 totalExercise: $4.97Exp: 2032-02-01→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on February 1, 2023 and thereafter the remaining shares vest and become exercisable in equal monthly installments over the following 24 months.